Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suman Gupta

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2020
Febrile temperature change modulates CD4 T cell differentiation via a TRPV channel-regulated Notch-dependent pathwayDanish Umar, Arundhoti Das, Suman Gupta, et al.
European Journal of Pharmacology|February 26, 2009
RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasiaKamna Nanda, Krishna S Naruganahalli, Suman Gupta, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogsVadiraj S Gopinath, Mukkavilli Rao, Rahul Shivahare, et al.
Journal of Medicinal Chemistry|April 25, 2013
Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agentsMoni Sharma, Kuldeep Chauhan, Rahul Shivahare, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonistsNaresh Kumar, Kirandeep Kaur, Shelly Aeron, et al.
Journal of Medicinal Chemistry|February 23, 2016
Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Adrian Blaser, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Design, synthesis and activity of novel derivatives of oxybutynin and tolterodineKirandeep Kaur, Shelly Aeron, Miriyala Bruhaspathy, et al.
Ticks and Tick-Borne Diseases|January 3, 2016
Chemo-profiling and bioassay of phytoextracts from Ageratum conyzoides for acaricidal properties against Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) infesting cattle and buffaloes in IndiaK G Ajith Kumar, Amol B Tayade, Rajesh Kumar, et al.
European Journal of Medicinal Chemistry|August 31, 2015
Aminothiazoles: Hit to lead development to identify antileishmanial agentsDebnath Bhuniya, Rao Mukkavilli, Rahul Shivahare, et al.
European Journal of Medicinal Chemistry|December 3, 2020
Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisalAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2020
Febrile temperature change modulates CD4 T cell differentiation via a TRPV channel-regulated Notch-dependent pathwayDanish Umar, Arundhoti Das, Suman Gupta, et al.
European Journal of Pharmacology|February 26, 2009
RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasiaKamna Nanda, Krishna S Naruganahalli, Suman Gupta, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogsVadiraj S Gopinath, Mukkavilli Rao, Rahul Shivahare, et al.
Journal of Medicinal Chemistry|April 25, 2013
Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agentsMoni Sharma, Kuldeep Chauhan, Rahul Shivahare, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonistsNaresh Kumar, Kirandeep Kaur, Shelly Aeron, et al.
Journal of Medicinal Chemistry|February 23, 2016
Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral LeishmaniasisAndrew M Thompson, Patrick D O'Connor, Adrian Blaser, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Design, synthesis and activity of novel derivatives of oxybutynin and tolterodineKirandeep Kaur, Shelly Aeron, Miriyala Bruhaspathy, et al.
Ticks and Tick-Borne Diseases|January 3, 2016
Chemo-profiling and bioassay of phytoextracts from Ageratum conyzoides for acaricidal properties against Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) infesting cattle and buffaloes in IndiaK G Ajith Kumar, Amol B Tayade, Rajesh Kumar, et al.
European Journal of Medicinal Chemistry|August 31, 2015
Aminothiazoles: Hit to lead development to identify antileishmanial agentsDebnath Bhuniya, Rao Mukkavilli, Rahul Shivahare, et al.
European Journal of Medicinal Chemistry|December 3, 2020
Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisalAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Pageof 14